Novavax stock falls 20% as vaccine maker misses quarterly estimates, sees sluggish 2024 sales

Read Time:7 Second

Novavax narrowed its losses in the quarter compared to the same period a year ago, even as demand for Covid products continues to plummet worldwide.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

Charter Communications is rolling out new pricing and commitments of reliability as it contends with industry shifts in broadband, TV...

Boeing also said it will pause nonessential staff travel and reduce supplier spending as it deals with a strike of...

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind...

Disney and DirecTV have reached a deal to end a blackout in time for college football this weekend.

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.

Critics say Shein and Temu are able to offer low prices because they evade import duties under the de minimis...